“…Mammogram-based breast cancer studies can also be categorized based on their utilization of input data into several groups: those focusing on unimodal data, which may encompass whole mammograms [19]- [22], [25], [28], [29], [32], [33], [33], [35], [37]- [39], [41], [44], [48], [52]- [56] or lesion crops [18], [27], [34], [36], [40], [51], [57]; others concentrating on multi-view mammograms [17], [30], [50], [58], [58]- [63]; some addressing both whole mammograms and lesion crops [26], [31], [42]; and additional investigations involving the integration of multiple modalities, such as the combination of mammograms with ultrasounds or electronic health records (EHRs) [36], [49], [54], [64]- [72]. In this work, we focus on two modalities: mammogram-based lesion crops and EHR data containing radiographic features and clinical patient metadata for breast cancer prediction.…”